C. Nieder

R. Bremnes, N. Andratschke, C. Nieder, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases

C. Nieder, K. Schwerdtfeger, W. Steudel, 1998, Strahlentherapie und Onkologie.

Prognostic indices for brain metastases – usefulness and challenges

M. Mehta, C. Nieder, 2009, Radiation oncology.

Presentation and outcome in cancer patients with extensive spread to the brain

C. Nieder, A. Dalhaug, Adam Pawiniski, 2009, BMC Research Notes.

Prognostic scores in brain metastases from breast cancer

M. Molls, C. Nieder, S. Astner, 2009, BMC Cancer.

The Role of Postoperative Radiotherapy after Resection of a Single Brain Metastasis

A. Grosu, N. Andratschke, M. Molls, 2007, Strahlentherapie und Onkologie.

Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors

A. Grosu, R. Thamm, M. Molls, 2006, Radiation oncology.

Recursive Partitioning Analysis (RPA) Class Does Not Predict Survival in Patients with Four or More Brain Metastases

A. Grosu, N. Andratschke, M. Molls, 2001, Strahlentherapie und Onkologie.

Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic radiosurgery plus whole-brain radiotherapy.

U. Nestle, C. Nieder, K. Schnabel, 2000, American journal of clinical oncology.

Dose/effect relationships for brain metastases

U. Nestle, C. Nieder, K. Schnabel, 1998, Journal of Cancer Research and Clinical Oncology.

Accelerated radiotherapy for brain metastases.

U. Nestle, C. Nieder, K. Schnabel, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

C. Nieder, K. Schnabel, W. Berberich, 1997, International journal of radiation oncology, biology, physics.

Relation between local result and total dose of radiotherapy for brain metastases.

U. Nestle, C. Nieder, K. Schnabel, 1995, International journal of radiation oncology, biology, physics.

Value of surgery and radiotherapy in the treatment of brain metastases

C. Nieder, K. Schnabel, M. Niewald, 1994 .

Symptom Burden in Patients Treated With Palliative Radiotherapy Before and During the COVID-19 Pandemic

C. Nieder, A. Winther, Silje Johnsen, 2021, AntiCancer Research.

Effects of Smoking Cessation on Hypoxia and its Potential Impact on Radiation Treatment Effects in Lung Cancer Patients

R. Bremnes, C. Nieder, 2008, Strahlentherapie und Onkologie.

Radiation therapy alone as an alternative to surgery in patients with early stage non-small-cell lung cancer having cardiovascular (and other) comorbidity.

B. Jeremic, M. Molls, C. Nieder, 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Conformal Therapy: Treatment Planning, Treatment Delivery, and Clinical Results

Charles R. Thomas, V. Budach, J. Cooper, 2013 .

A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question?

M. Guckenberger, N. Andratschke, C. Nieder, 2015, Annals of translational medicine.

Strategies for Modification of the Radiation Response of the Lung

C. Nieder, 2003 .

4 Strategies for Mod i fi ca tion of the Radiation Re sponse of the Lung

C. Nieder, 2003 .

Simultaneous precise chemoradiation under inhalation anesthesia in an experimental mouse tumor model.

M. Molls, C. Nieder, J. Henke, 2005, Anticancer research.

Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2020, Cureus.

Provider decision regret—a useful method for analysis of palliative thoracic re-irradiation for lung cancer?

C. Nieder, E. Haukland, B. Mannsăker, 2020, Strahlentherapie und Onkologie.

Head and Neck Squamous Cell Cancer

C. Nieder, 2013 .

Expert consensus on re-irradiation for recurrent glioma

K. Camphausen, C. Tsien, J. Fiveash, 2017, Radiation Oncology.

Extracranial oral cavity metastasis from glioblastoma multiforme: A case report.

C. Nieder, I. Adamietz, G. Winnekendonk, 2016, Molecular and clinical oncology.

Contribution of case reports to glioblastoma research: Systematic review and analysis of pattern of citation

C. Nieder, A. Pawinski, A. Dalhaug, 2012, British journal of neurosurgery.

Mammographic screening in Sami speaking municipalities and a control group. Are early outcome measures influenced by ethnicity?

S. Hofvind, C. Nieder, J. Norum, 2012, International journal of circumpolar health.

Comorbidity, Use of Common Medications, and Risk of Early Death in Patients with Localized or Locally Advanced Prostate Cancer

C. Nieder, J. Norum, A. Pawinski, 2011, TheScientificWorldJournal.

Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer.

B. Jeremic, N. Andratschke, M. Molls, 2003, Anticancer research.

Impact of comorbidity on survival after palliative radiotherapy

C. Nieder, K. Engljähringer, Kent Angelo, 2014, Strahlentherapie und Onkologie.

Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care

B. Vonen, C. Nieder, C. von Plessen, 2019, BMC Palliative Care.

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

N. Andratschke, M. Molls, C. Nieder, 2008, Radiation oncology.

Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review.

C. Peschel, N. Andratschke, M. Molls, 2003, Cancer treatment reviews.

Combinations of Platinum Compounds and Ionizing Radiation

F. Lordick, C. Nieder, 2006 .

Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.

P. Kneschaurek, M. Molls, C. Nieder, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy for nonagenarians: the value of biological versus chronological age

C. Zamboglou, A. Grosu, N. Nicolay, 2020, Radiation oncology.

The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases

C. Nieder, A. Grosu, O. Oehlke, 2017, Clinical and Translational Oncology.

Differences in quality of life in obese and normal weight head and neck cancer patients undergoing radiation therapy

C. Nieder, H. Egestad, 2015, Supportive Care in Cancer.

Radiation myelopathy: new perspective on an old problem.

K. Ang, R. Price, C. Nieder, 1999, Radiation oncology investigations.

Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.

C. Nieder, A. Pawinski, A. Dalhaug, 2016, In vivo.

Initial Experience after Transition to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer Treated in a Rural Healthcare Region

C. Nieder, T. Tollåli, Anne Reigstad, 2020, Cureus.

Patient-reported Symptom Burden, Rate of Completion of Palliative Radiotherapy and 30-day Mortality in Two Groups of Cancer Patients Managed With or Without Additional Care by a Multidisciplinary Palliative Care Team.

C. Nieder, A. Dalhaug, E. Haukland, 2018, Anticancer research.

Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison

C. Nieder, A. Pawinski, A. Dalhaug, 2015, Radiation Oncology.

Palliative Radiotherapy with or without Additional Care by a Multidisciplinary Palliative Care Team: A Retrospective Comparison

C. Nieder, A. Pawinski, G. Aandahl, 2014, ISRN oncology.

Early palliative care in patients with metastatic non-small cell lung cancer.

C. Nieder, J. Norum, 2012, Annals of palliative medicine.

Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factor.

K. Ang, R. Price, S. Tucker, 2004, International journal of radiation oncology, biology, physics.

Assessment of extracranial metastatic disease in patients with brain metastases: how much effort is needed in the context of evolving survival prediction models?

M. Mehta, D. de Ruysscher, L. Gaspar, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies

P. Vaupel, M. Anscher, M. Molls, 2009 .

Theoretical Medicine

L. Mell, A. Mundt, D. Michalski, 2022 .

Multimodal Concepts for Integration of Cytotoxic Drugs

M. Mehta, J. Brown, C. Nieder, 2006 .

Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases

C. Nieder, A. Pawinski, G. Aandahl, 2014, Medical Oncology.

Contribution of Case Reports to Brain Metastases Research: Systematic Review and Analysis of Pattern of Citation

C. Nieder, A. Pawinski, A. Dalhaug, 2012, PloS one.

Preserving the legacy of reirradiation: A narrative review of historical publications

A. Grosu, J. Langendijk, M. Guckenberger, 2017, Advances in radiation oncology.

Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles.

A. Grosu, N. Andratschke, C. Nieder, 2013, American journal of cancer research.

A thought-provoking retrospective study on survival and toxicity after reirradiation for recurrent high-grade gliomas.

C. Nieder, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retreatment of the spinal cord with palliative radiotherapy.

A. Grosu, N. Andratschke, M. Molls, 2002, International journal of radiation oncology, biology, physics.

Tissue tolerance to reirradiation.

K. Ang, L. Milas, C. Nieder, 2000, Seminars in radiation oncology.

Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases

C. Nieder, A. Pawinski, A. Dalhaug, 2010, BMC Cancer.

Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma.

C. Nieder, M. Adam, S. Astner, 2008, Anticancer research.

European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.

D. de Ruysscher, Y. M. van der Linden, P. Hoskin, 2022, The Lancet. Oncology.

Does distance to treatment centre influence the rate of palliative radiotherapy in adult cancer patients?

C. Nieder, J. Norum, O. Spanne, 2009, Anticancer research.

Management of Patients With Metastatic Renal Cell Cancer and Bone Metastases

C. Nieder, A. Pawinski, A. Dalhaug, 2020, In Vivo.

Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region

C. Nieder, J. Norum, A. Pawinski, 2017, Medical Oncology.

Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?

C. Nieder, J. Norum, A. Dalhaug, 2019, International journal of circumpolar health.

Colorectal cancer metastatic to the brain: analysis of prognostic factors and impact of KRAS mutations on presentation and outcome

C. Nieder, A. Grosu, M. Hintz, 2015, Clinical and Translational Oncology.

Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?

C. Nieder, A. Pawinski, T. Tollåli, 2017, Journal of clinical medicine research.

Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancer.

A. Grosu, M. Molls, C. Nieder, 2007, Anticancer research.

Front‐line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma

C. Nieder, 1999, Cancer.

Initiation of Systemic Therapy During the Last 30 Days of Life in Patients With Metastatic Castration-resistant Prostate Cancer

C. Nieder, J. Norum, A. Pawinski, 2018, AntiCancer Research.

The challenge of durable brain control in patients with brain-only metastases from breast cancer

A. Grosu, C. Nieder, O. Oehlke, 2015, SpringerPlus.

Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous

Timothy K. Nguyen, M. Mehta, D. de Ruysscher, 2019, Radiation Oncology.

Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU

F. Lordick, H. Geinitz, M. Molls, 2014, Strahlentherapie und Onkologie.

Risk factors and dose-effect relationship for osteoradionecrosis after hyperfractionated and conventionally fractionated radiotherapy for oral cancer.

C. Nieder, K. Schnabel, M. Niewald, 1996, The British journal of radiology.

Impact of body mass index on outcomes after conformal radiotherapy in patients with prostate cancer.

H. Geinitz, R. Thamm, M. Molls, 2011, International journal of radiation oncology, biology, physics.

Second re-irradiation: a narrative review of the available clinical data

A. Grosu, J. Langendijk, M. Guckenberger, 2017, Acta oncologica.

Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?

M. Molls, C. Nieder, A. Pawinski, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?

C. Nieder, J. Norum, A. Dalhaug, 2008, Journal of oncology.

Disease Presentation and Treatment Outcome in Very Young Patients with Brain Metastases from Lung Cancer

R. Thamm, M. Molls, C. Nieder, 2008, Oncology Research and Treatment.

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer

C. Nieder, E. Haukland, B. Mannsăker, 2020, Radiation oncology.

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection

A. Grosu, C. Nieder, S. Combs, 2018, Cancer medicine.

New clinical data on human spinal cord re-irradiation tolerance

K. Tamari, C. Nieder, R. Oh, 2021, Strahlentherapie und Onkologie.

Local control and overall survival after frameless radiosurgery: A single center experience

A. Grosu, C. Nieder, R. Wiehle, 2017, Clinical and translational radiation oncology.

Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus

H. Geinitz, C. Nieder, S. Combs, 2015, Strahlentherapie und Onkologie.

Undesirable financial effects of head and neck cancer radiotherapy during the initial treatment period

C. Nieder, H. Egestad, 2015, International journal of circumpolar health.

Influence of different treatment techniques on radiation dose to the LAD coronary artery

P. Kneschaurek, M. Molls, C. Nieder, 2007, Radiation oncology.

Detrimental effects of an antibody directed against tumor necrosis factor alpha in experimental kidney irradiation.

M. Schwaiger, W. Weber, N. Andratschke, 2006, Anticancer research.

Evaluation of insulin-like growth factor-1 in a mouse model of long-term abdominal radiation toxicity.

M. Schwaiger, W. Weber, N. Andratschke, 2007, Anticancer research.

Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction.

M. Schwaiger, W. Weber, N. Andratschke, 2006, International journal of radiation oncology, biology, physics.

Risk Factors for Local Relapse and Inferior Disease‐free Survival After Breast‐conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients

H. Thames, H. Geinitz, C. Nieder, 2019, Clinical breast cancer.

External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer

A. Grosu, C. Nieder, I. Popp, 2022, Current oncology.

30-day mortality in patients treated for brain metastases: extracranial causes dominate

C. Nieder, S. G. Aanes, E. Haukland, 2022, Radiation oncology.

The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy

C. Nieder, A. Dalhaug, E. Haukland, 2021, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Recursive Partitioning Analysis of Systemic Therapy after Radiotherapy in Patients with Brain Metastases

C. Nieder, A. Dalhaug, E. Haukland, 2021, Oncology Research and Treatment.

Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2021, Anticancer Research.

In regard to Vesprini et al.

C. Nieder, 2013, International journal of radiation oncology, biology, physics.

Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients - Long term data on toxicity and biochemical control.

M. Duma, H. Geinitz, M. Molls, 2019, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Prediction of very short survival in patients with brain metastases from breast cancer.

R. Thamm, M. Molls, C. Nieder, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prediction of very short survival in patients with brain metastases from non-small cell lung cancer

R. Thamm, M. Molls, C. Nieder, 2008 .

Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity?

N. Andratschke, M. Molls, C. Nieder, 2007, Journal of the National Cancer Institute.

Brain metastases from HER2-positive breast cancer.

C. Nieder, 2013, The Lancet. Oncology.

Prevention of radiation-induced central nervous system toxicity: a role for amifostine?

N. Andratschke, M. Molls, C. Nieder, 2004, Anticancer research.

Hematopoietic Tissue II: Role of Colony-Stimulating Factors

B. Jeremic, C. Nieder, T. Licht, 2003 .

Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations

M. Mehta, D. Ruysscher, L. Gaspar, 2018, Strahlentherapie und Onkologie.

Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients.

A. Grosu, N. Andratschke, M. Molls, 2005, International journal of radiation oncology, biology, physics.

Necessity of identifying the patterns of failure after concurrent radiochemotherapy part of a combined modality approach in patients with stage III non-small cell lung cancer [Sakai et al., Lung Cancer 2004;43:195-201].

B. Jeremic, M. Molls, C. Nieder, 2004, Lung cancer.

Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases

H. Urbach, A. Grosu, C. Nieder, 2016, Clinical Neurology and Neurosurgery.

Clinical effectiveness of radiotherapy for non-Hodgkin's lymphoma: a summary.

C. Nieder, 2004, Cancer treatment reviews.

Treatment of newly diagnosed glioblastoma multiforme.

C. Nieder, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accelerated hyperfractionated irradiation combined with difluoromethylornithine is no more effective than standard radiotherapy for glioblastoma multiforme

C. Nieder, 2001 .

Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?

H. Geinitz, A. Grosu, C. Nieder, 2011, Journal of cancer research and therapeutics.

Polypharmacy in Older Patients ≥70 Years Receiving Palliative Radiotherapy.

C. Nieder, A. Pawinski, E. Haukland, 2017, Anticancer research.

Outcomes of Patients with Squamous Cell Carcinoma of Esophagus who did not receive Surgical Resection after Neoadjuvant Radiochemotherapy

F. Lordick, H. Geinitz, C. Nieder, 2015, Tumori.

Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.

T. Schuster, H. Geinitz, C. Nieder, 2014, Anticancer Research.

Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer

C. Nieder, S. G. Aanes, E. Haukland, 2022, AntiCancer Research.

Seven-month prostate-specific antigen (PSA) is prognostic in patients with prostate cancer initially diagnosed with distant metastases

C. Nieder, J. Norum, A. Pawinski, 2018, Medical Oncology.

A Case of Five-Year Survival After Combined-Modality Treatment for Non-Small Cell Lung Cancer With Intraspinal Metastasis

C. Nieder, B. Mannsăker, Bărd Mannsăker, 2022, Cureus.

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

A. Grosu, N. Andratschke, M. Molls, 2004, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?

C. Nieder, E. Haukland, B. Mannsăker, 2021, In Vivo.

Health Economics and Radium-223 (Xofigo®) in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case History and a Systematic Review of the Literature

J. Olsen, C. Nieder, J. Norum, 2015, Global journal of health science.

Late residual gamma-H2AX foci in murine spinal cord might facilitate development of response-modifying strategies: a research hypothesis.

N. Andratschke, C. Nieder, T. Blau, 2011, Anticancer research.

Postoperative treatment and prognosis of patients with resected single brain metastasis: How useful are established prognostic scores?

C. Nieder, S. Astner, K. Marienhagen, 2011, Clinical Neurology and Neurosurgery.

Two New Prognostic Indices for Brain Metastases – Where Do We Go from Here?

C. Nieder, 2008, Strahlentherapie und Onkologie.

Acceleration of Normal-Tissue Damage Expression by Early Stimulation of Cell Proliferation in Rat Spinal Cord

R. Price, N. Andratschke, C. Nieder, 2006, Strahlentherapie und Onkologie.

External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment

C. Nieder, V. Lewitzki, S. Hess, 2020, Oncology Research and Treatment.

Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement

C. Nieder, A. Dalhaug, B. Mannsăker, 2022, In Vivo.

Serum Lactate Dehydrogenase Contributes to Prognostic Assessment in Patients With Oligometastatic Cancer and Brain Involvement

C. Nieder, A. Pawinski, A. Dalhaug, 2018, In Vivo.

Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents

C. Nieder, S. G. Aanes, E. Haukland, 2022, Journal of Cancer Research and Clinical Oncology.

Validation of a Graded Prognostic Model in Patients With Brain Metastases Treated With Whole-brain Radiotherapy Instead of Radiosurgery

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2021, In Vivo.

Expansion of the LabBM Score

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2020, American journal of clinical oncology.

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2020, Cureus.

Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)

A. Grosu, C. Nieder, A. Bilger, 2020, Radiation oncology.

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)

A. Grosu, C. Nieder, O. Oehlke, 2017, Radiation Oncology.

Palliative radiotherapy in patients with metastatic non-small cell lung cancer.

C. Nieder, J. Norum, 2013, Annals of palliative medicine.

Predicted survival in patients with brain metastases from colorectal cancer: Is a current nomogram helpful?

A. Grosu, C. Nieder, M. Hintz, 2016, Clinical Neurology and Neurosurgery.

Scylla or Charybdis: Case Report on Radiation Tolerance of the Spinalcord

C. Nieder, A. Pawinski, A. Dalhaug, 2011 .

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer

N. Andratschke, C. Nieder, A. Pawinski, 2012, Radiation oncology.

Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence

C. Nieder, J. Norum, 2017, PharmacoEconomics.

Current status of angiogenesis inhibitors combined with radiation therapy.

N. Andratschke, M. Molls, C. Nieder, 2006, Cancer treatment reviews.

Radiotherapy-induced lung toxicity: risk factors and prevention strategies.

B. Jeremic, M. Molls, C. Nieder, 2003, Anticancer research.

Re-Irradiation: New Frontiers

J. Langendijk, C. Nieder, 2017, Medical Radiology.

Response Monitoring by Positron Emission Tomography during Radiotherapy of a Squamous Cell Skin Carcinoma

A. Grosu, C. Nieder, 2005, Oncology Research and Treatment.

Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiation

N. Andratschke, C. Nieder, S. Astner, 2007, Radiation oncology.

Mechanisms and Modification of the Radiation Response of the Central Nervous System

K. Ang, N. Andratschke, C. Nieder, 2003 .

Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents

A. Eisbruch, C. Nieder, 2010 .

Quantitative Cell Kill of Radio- and Chemotherapy

C. Belka, M. Molls, C. Nieder, 2009 .

Biological Basis of Combined Radio- and Chemotherapy

C. Belka, M. Molls, C. Nieder, 2006 .

Therapeutic options for recurrent high-grade glioma in adult patients: recent advances.

A. Grosu, M. Molls, C. Nieder, 2006, Critical reviews in oncology/hematology.

Applications in Malignant Brain Tumors

M. Gilbert, C. Nieder, 2006 .

Combined modality treatment of glioblastoma multiforme: the role of temozolomide.

A. Grosu, C. Nieder, M. Adam, 2006, Reviews on recent clinical trials.

Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature

C. Nieder, J. Norum, 2018, ESMO Open.

Report of a male patient with brain metastases from breast cancer.

C. Peschel, M. Molls, C. Nieder, 2003, Breast.

Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases.

U. Abel, C. Nieder, R. Kubale, 1996, International journal of radiation oncology, biology, physics.

Resource Utilization in Patients with Brain Metastases Managed with Best Supportive Care, Radiotherapy and/or Surgical Resection: A Markov Analysis

C. Nieder, J. Norum, A. Dalhaug, 2010, Oncology.

Presentation, patterns of care, and survival in patients with brain metastases

M. Mehta, H. Geinitz, A. Grosu, 2011, Cancer.

Palliative radiotherapy during the last month of life: Predictability for referring physicians and radiation oncologists.

C. Nieder, J. Norum, A. Pawinski, 2015, Oncology letters.

Induced abortion on demand and birth rate in Sami-speaking municipalities and a control group in Finnmark, Norway

C. Nieder, J. Norum, A. Heyd, 2013, International journal of circumpolar health.

Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancer.

H. Geinitz, C. Nieder, J. Norum, 2011, Anticancer research.

Second re-irradiation: A delicate balance between safety and efficacy.

C. Nieder, 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Health consumption in Sami-speaking municipalities with regard to cancer and radiotherapy

C. Nieder, M. Småstuen, J. Norum, 2011, International journal of circumpolar health.

A Case of Recurrent Breast Cancer with Solitary Metastasis to the Urinary Bladder

C. Nieder, A. Pawinski, 2014, Case reports in oncological medicine.

Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC).

R. Soffietti, M. Guckenberger, N. Andratschke, 2019, Lung cancer.

Mechanisms of Treatment Resistance: Molecular and Clinical Examples for Radio- and Chemotherapy

C. Nieder, 2009 .

Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicity

A. Grosu, M. Molls, C. Nieder, 2007, Journal of Cancer Research and Clinical Oncology.

Survival after palliative radiotherapy in geriatric cancer patients.

C. Nieder, A. Pawinski, E. Haukland, 2014, Anticancer research.

Feasibility of radiotherapy in nonagenarian patients: a retrospective study

H. Geinitz, C. Nieder, M. Geier, 2018, Strahlentherapie und Onkologie.

How Should Palliative Thoracic Radiotherapy Be Fractionated for Octogenarians with Lung Cancer?

C. Nieder, A. Dalhaug, B. Mannsăker, 2018, In vivo.

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)

C. Nieder, Thomas A. Kämpe, 2017, Technical innovations & patient support in radiation oncology.

Continuous controversy about radiation oncologists’ choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

C. Nieder, A. Pawinski, A. Dalhaug, 2013, Radiation Oncology.

Primary Tumour Characteristics as Potential Prognostic Factors in Brain Metastases from Breast Cancer

C. Nieder, O. Spanne, A. Dalhaug, 2010 .

Stereotactic radiation therapy for liver metastases: factors affecting local control and survival

N. Andratschke, M. Molls, C. Nieder, 2015, Radiation oncology.

Stereotactic radiation therapy for liver metastases: factors affecting local control and survival

N. Andratschke, M. Molls, C. Nieder, 2015, Radiation Oncology.

Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.

U. Nestle, C. Nieder, W. Steudel, 1999, Radiation oncology investigations.

The results of colorectal cancer treatment by p53 status

H. Thames, C. Nieder, C. Petersen, 2001, Diseases of the colon and rectum.

A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma

C. Nieder, M. A. Syed, 2017, Journal of clinical medicine research.

Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies

H. Geinitz, A. Grosu, C. Nieder, 2012, Strahlentherapie und Onkologie.

Radiotherapy and Chemotherapy for Myoepithelioma of the Sellar Region

A. Grosu, C. Peschel, F. Schneller, 2005, Strahlentherapie und Onkologie.

Combined radio- and chemotherapy of brain tumours in adult patients.

M. Mehta, C. Nieder, R. Jalali, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review

L. Gaspar, A. Grosu, C. Nieder, 2014, Radiation oncology.

Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.

W. Yuh, M. Bock, H. Urbach, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Analysis of long-term survivors of glioblastoma multiforme in a single institution with aggressive local retreatment protocol.

A. Grosu, M. Molls, C. Nieder, 2007, Anticancer research.

Re-irradiation for Recurrent Primary Brain Tumors.

A. Grosu, N. Andratschke, C. Nieder, 2016, Anticancer research.

Repeated localized treatment for extranodal marginal zone lymphoma--case report and review of literature.

M. Molls, C. Nieder, S. Astner, 2011, Anticancer research.

Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents

M. Mehta, A. Grosu, N. Andratschke, 2004, Expert review of neurotherapeutics.

Continuous controversy about radiation oncologists’ choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

C. Nieder, A. Pawinski, A. Dalhaug, 2013, Radiation oncology.

Does Marital Status Influence Levels of Anxiety and Depression Before Palliative Radiotherapy?

C. Nieder, Thomas A. Kämpe, 2018, In vivo.

Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?

C. Nieder, Rosalba Yobuta, K. Imingen, 2021, Anticancer Research.

Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease

M. Mehta, D. de Ruysscher, L. Gaspar, 2017, Strahlentherapie und Onkologie.

Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?

U. Nestle, C. Nieder, K. Schnabel, 2000, International journal of radiation oncology, biology, physics.

Brain metastases in renal cell cancer: diagnostic and therapeutic aspects.

A. Grosu, J. Schlegel, M. Molls, 2004, American Journal of Clinical Oncology.

Disease Presentation and Outcome in Very Young Patients with Brain Metastases from Breast Cancer

N. Andratschke, C. Nieder, M. Adam, 2008, Tumori.

Does overall treatment time impact on survival after whole-brain radiotherapy for brain metastases?

H. Geinitz, A. Grosu, N. Andratschke, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.

A. Grosu, C. Nieder, N. Wiedenmann, 2013, International journal of radiation oncology, biology, physics.

Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases

L. Frings, A. Grosu, C. Nieder, 2015, Strahlentherapie und Onkologie.

Validation of the graded prognostic assessment index for patients with brain metastases

H. Geinitz, M. Molls, C. Nieder, 2009, Acta oncologica.

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review

Carsten Nieder, L. Gaspar, A. Grosu, 2014, Radiation Oncology.

Stereotactic radiosurgery for brain metastasis from renal cell carcinoma

D. Kondziolka, J. Flickinger, L. Lunsford, 1998, Cancer.

Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer.

C. Nieder, J. Norum, E. Haukland, 2016, Oncology letters.

11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.

Wolfgang A Weber, Michael Molls, Markus Schwaiger, 2006, International journal of radiation oncology, biology, physics.

Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids

C. Nieder, J. Norum, G. Aandahl, 2013, Supportive Care in Cancer.

[Stereotactic radiation therapy with a modified linear accelerator in patients with brain metastases].

P. Kneschaurek, M. Pinsker, H. Feldmann, 2001, Der Nervenarzt.

Treatment of brain metastases from renal cell cancer.

C. Nieder, O. Spanne, T. Nordøy, 2011, Urologic oncology.

Leptomeningeal carcinomatosis from renal cell cancer: treatment attempt with radiation and sunitinib (case report)

C. Nieder, A. Dalhaug, E. Haukland, 2010, World journal of surgical oncology.

Ten years disease-free survival after solitary brain metastasis from breast cancer

U. Nestle, C. Nieder, K. Schnabel, 2005, Journal of Cancer Research and Clinical Oncology.

Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs.

K Schnabel, U Nestle, U. Nestle, 1999, American journal of clinical oncology.

Radiation Therapy in Brain Metastasis of Solid Tumors: A Challenge for the Future

A. Grosu, C. Nieder, O. Oehlke, 2018 .

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)

A. Grosu, C. Nieder, O. Oehlke, 2018, Journal of clinical medicine research.

Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.

C. Nieder, A. Pawinski, G. Aandahl, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors

C. Nieder, J. Norum, A. Pawinski, 2013, Clinical & Experimental Metastasis.

An uncommon presentation and course of metastatic malignant melanoma: a case report

C. Nieder, J. Norum, A. Pawinski, 2007, Journal of medical case reports.

Colorectal Cancer Metastatic to the Brain: Time Trends in Presentation and Outcome

C. Nieder, L. Balteskard, A. Pawinski, 2009, Oncology.

Stereotactic Fractionated Radiotherapy for Recurrent Capillary Hemangioma of the Cavernous Sinus

A. Grosu, C. Nieder, 2006, Strahlentherapie und Onkologie.

A comparison of treatment results for recurrent malignant gliomas.

M Molls, M. Molls, C. Nieder, 2000, Cancer treatment reviews.

Perspectives in the treatment of malignant gliomas in adults.

M Molls, N. Andratschke, M. Molls, 2001, Anticancer research.

[Correlation of preoperative neuroradiologic with postoperative histologic diagnosis in pathological intracranial processes].

J. Moringlane, C. Nieder, W. Feiden, 1995, Der Radiologe.

Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept

J. Pichler, H. Geinitz, C. Nieder, 2018, Clinical and Translational Oncology.

Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.

M. Mehta, C. Nieder, 2011, Medical hypotheses.

Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme.

A. Grosu, M. Molls, C. Nieder, 2006, Anticancer research.

Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy

C. Nieder, A. Dalhaug, B. Mannsăker, 2020, Journal of clinical medicine research.

Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance

C. Nieder, A. Pawinski, A. Dalhaug, 2017, International journal of circumpolar health.

Multivariate logistic analysis of dose-effect relationship and latency of radiomyelopathy after hyperfractionated and conventionally fractionated radiotherapy in animal experiments.

U. Abel, U. Nestle, C. Nieder, 1998, International journal of radiation oncology, biology, physics.

Combinations of Cytotoxic Drugs, Ionizing Radiation, and Angiogenesis Inhibitors

N. Andratschke, C. Nieder, 2006 .

Endovascular Brachytherapy to Prevent Restenosis After Percutaneous Coronary Intervention

M. Molls, C. Nieder, R. Baum, 2014 .

Does Patient-reported Dyspnea Reflect Thoracic Disease Characteristics in Patients with Incurable Cancer?

C. Nieder, Thomas A. Kämpe, Kirsten Engljähringer, 2018, Anticancer research.

In response to Drs. Byhardt and Scott

U. Abel, U. Nestle, C. Nieder, 2001 .

Sami-speaking municipalities and a control group's access to somatic specialist health care (SHC): a retrospective study on general practitioners’ referrals

C. Nieder, J. Norum, 2012, International journal of circumpolar health.

[Association of HPV infection, p16 status, and efficacy of radiotherapy with or without cetuximab in advanced oropharyngeal squamous cell carcinoma].

C. Nieder, 2016, Strahlentherapie und Onkologie (Print).

Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy

C. Nieder, A. Pawinski, A. Dalhaug, 2017, Journal of clinical medicine research.

Palliative Radiotherapy in Cancer Patients with Increased Serum C-Reactive Protein Level.

C. Nieder, A. Pawinski, A. Dalhaug, 2016, In vivo.

A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC).

U. Abel, U. Nestle, C. Nieder, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy

Carsten Nieder, C. Nieder, A. Pawinski, 2014, ISRN oncology.

Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965).

N. Andratschke, C. Nieder, 2007, International journal of radiation oncology, biology, physics.

A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study.

U. Abel, U. Nestle, C. Nieder, 2000, International journal of radiation oncology, biology, physics.

Radiomyelopathy after conventionally fractionated and hyperfractionated radiotherapy--experimental data and clinical consequences.

U. Abel, U. Nestle, C. Nieder, 1999, Frontiers of radiation therapy and oncology.

Treatment of brain metastases from hypernephroma.

C. Nieder, K. Schnabel, M. Niewald, 1996, Urologia internationalis.

Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life

C. Nieder, E. Haukland, Bărd Mannsăker, 2022, Cureus.

Survival and Symptom Relief after Palliative Radiotherapy for Esophageal Cancer

C. Nieder, I. Adamietz, V. Khosrawipour, 2016, Journal of Cancer.

Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors

C. Nieder, E. Haukland, B. Mannsăker, 2023, Radiation Oncology.

The LabPS score

C. Nieder, A. Dalhaug, E. Haukland, 2023 .

Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation

C. Nieder, A. Dalhaug, E. Haukland, 2023, Strahlentherapie und Onkologie.

The LabPS score: Inexpensive, Fast, and Site-agnostic Survival Prediction.

C. Nieder, A. Dalhaug, E. Haukland, 2022, American Journal of Clinical Oncology.

Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2022, AntiCancer Research.

In Regard to Alcorn et al.

C. Nieder, 2021, International journal of radiation oncology, biology, physics.

Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases

C. Nieder, B. Mannsăker, Rosalba Yobuta, 2021, AntiCancer Research.

Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms.

M. Mehta, H. Geinitz, A. Grosu, 2018, Critical reviews in oncology/hematology.

External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer

C. Nieder, A. Dalhaug, E. Haukland, 2017, Clinical lung cancer.

Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer

C. Nieder, Luka Stanisavljević, 2022, AntiCancer Research.

Validation of New Prognostic and Predictive Scores by Sequential Testing Approach

Carsten Nieder, C. Nieder, A. Pawinski, 2010, Strahlentherapie und Onkologie.

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis

C. Nieder, Rosalba Yobuta, Bărd Mannsăker, 2022, Cureus.

Symptom Burden in Patients With Reduced Performance Status at the Start of Palliative Radiotherapy

C. Nieder, Thomas A. Kämpe, 2020, In Vivo.

Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.

C. Nieder, J. Norum, A. Pawinski, 2014, Anticancer research.

A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer

C. Nieder, A. Dalhaug, E. Haukland, 2018, Cancer Investigation.

Frequency and Prognostic Impact of Consistently Low Edmonton Symptom Assessment System Score in the Patients Treated with Palliative Radiotherapy

C. Nieder, Thomas A. Kämpe, 2018, Cureus.

Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?

C. Nieder, A. Pawinski, A. Dalhaug, 2014, Medical Principles and Practice.

Feasibility and efficacy of early docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in a rural health care setting

C. Nieder, A. Dalhaug, E. Haukland, 2022, Scandinavian journal of urology.

Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.

C. Nieder, Thomas A. Kämpe, 2018, Anticancer research.

Patterns of Treatment and Outcome in Patients With 20 or More Brain Metastases

C. Nieder, Rosalba Yobuta, Bărd Mannsăker, 2018, In Vivo.

Patient-reported symptoms before palliative radiotherapy predict survival differences

C. Nieder, A. Pawinski, A. Dalhaug, 2018, Strahlentherapie und Onkologie.

The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy

C. Nieder, A. Pawinski, A. Dalhaug, 2017, Molecular and clinical oncology.

Palliative radiotherapy (PRT) during the last month of life: A constant sorrow even in a dedicated PRT facility with research focus on this endpoint.

C. Nieder, 2015, Radiotherapy and Oncology.

Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival

C. Nieder, K. Imingen, 2023, In Vivo.

Early High-Grade Thoracic Toxicity After Palliative Radiotherapy for Non-Small Cell Lung Cancer

C. Nieder, K. Imingen, 2021, Cureus.

An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer

C. Nieder, K. Imingen, 2021, In Vivo.

Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram?

A. Grosu, C. Nieder, J. Norum, 2017, Journal of Cancer.

PV-0087: Improvement of models for survival prediction through inclusion of patient-reported symptoms

C. Nieder, A. Dalhaug, E. Haukland, 2017 .

Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer

C. Nieder, E. Haukland, T. Tollåli, 2016, Supportive Care in Cancer.

Development of a Score Predicting Survival after Palliative Reirradiation

A. Grosu, N. Andratschke, C. Nieder, 2014, Journal of oncology.

Feasibility and efficacy of sequential systemic therapy for metastatic castration-resistant prostate cancer in a rural health care setting

C. Nieder, A. Dalhaug, E. Haukland, 2020, Scandinavian journal of urology.

Symptom Burden in Patients With Oligometastases at the Start of Palliative Radiotherapy

C. Nieder, Thomas A. Kämpe, 2020, AntiCancer Research.

Palliative Thoracic Radiotherapy for Non-Small Cell Lung Cancer in Outpatients: Reasons for Unplanned Hospitalization and Its Impact on Survival

C. Nieder, E. Haukland, K. Imingen, 2021, Journal of clinical medicine research.

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases

C. Nieder, A. Pawinski, A. Dalhaug, 2010, BMC urology.

Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?

A. Grosu, N. Andratschke, C. Nieder, 2023, Seminars in radiation oncology.

Hippocampus-Avoidance Whole-Brain Radiation Therapy Is Efficient in the Long-Term Preservation of Hippocampal Volume

H. Urbach, M. Reisert, A. Grosu, 2021, Frontiers in Oncology.

Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.

L. Recht, M. Mehta, Jennifer A. Smith, 2009, International journal of radiation oncology, biology, physics.

Levels of Anxiety and Depression Before Palliative Reirradiation Are Comparable to Those Before First Palliative Radiotherapy

C. Nieder, Thomas A. Kämpe, 2018, Cureus.

Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations

N. Andratschke, C. Nieder, A. Pawinski, 2013, Front. Oncol..

[Prognostic benefit of postoperative radiotherapy with adjuvant chemotherapy for stage IIIA/N2, pathologic non-small-cell lung cancer].

C. Nieder, 2015, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Percent of remaining life on palliative radiation treatment: solely a function of fractionation?

C. Nieder, A. Dalhaug, B. Mannsăker, 2023, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

High-Precision Radiation Therapy with Integrated Biological Imaging and Tumor Monitoring

F. Nüsslin, M. Schwaiger, H. Geinitz, 2006, Strahlentherapie und Onkologie.

Nontargeted Effect after Radiotherapy in a Patient with Non-Small Cell Lung Cancer and Bullous Pemphigoid

C. Nieder, K. Al-Shibli, T. Tollåli, 2015, Case reports in oncological medicine.

Adding cetuximab to stereotactic radiotherapy for non-small cell lung cancer might reduce local failure rates.

N. Andratschke, C. Nieder, 2012, Medical hypotheses.

Fractionated stereotactic radiotherapy in the treatment of pituitary adenomas

B. Meyer, H. Geinitz, G. Stalla, 2013, Strahlentherapie und Onkologie.

Evaluation of insulin-like growth factor-1 for prevention of radiation-induced spinal cord damage

R. Price, N. Andratschke, C. Nieder, 2005, Growth factors.

Innovative prevention strategies for radiation necrosis of the central nervous system.

K. Ang, R. Price, N. Andratschke, 2002, Anticancer research.

[Experimental data for administration of insulin-like growth factor 1 (IGF-1) and basic fibroblast growth factor (bFGF) for prevention of radiation myelopathy].

K. Ang, R. Price, N. Andratschke, 2002, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Adverse events in hospitalised cancer patients: a comparison to a general hospital population

B. Vonen, C. Nieder, C. von Plessen, 2017, Acta oncologica.

[Event-free survival as a composite endpoint (commonly including PSA progression) is not a surrogate for overall survival after radiotherapy for localized prostate cancer].

C. Nieder, 2020, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors.

P. Kneschaurek, A. Grosu, M. Molls, 2006, International journal of radiation oncology, biology, physics.

Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery

C. Nieder, Rosalba Yobuta, Bărd Mannsăker, 2018, Cureus.

Contribution of adverse events to death of hospitalised patients

B. Vonen, C. Nieder, C. von Plessen, 2019, BMJ open quality.

Socioeconomic characteristics and health outcomes in Sami speaking municipalities and a control group in northern Norway

C. Nieder, J. Norum, 2012, International journal of circumpolar health.

Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience.

N. Andratschke, M. Molls, C. Nieder, 2007, Reviews on recent clinical trials.

Sami-speaking municipalities and a control group's access to somatic specialist health care (SHC): a retrospective study on general practitioners' referrals.

C. Nieder, J. Norum, 2012, International journal of circumpolar health.

The role of pentoxifylline as a modifier of radiation therapy.

M. Molls, C. Nieder, M. Adam, 2005, Cancer treatment reviews.

Is there a seasonal variation of survival after systemic chemotherapy for metastatic castration-resistant prostate cancer in a rural part of North Norway?

C. Nieder, A. Dalhaug, E. Haukland, 2020, International journal of circumpolar health.

Socioeconomic characteristics and health outcomes in Sami speaking municipalities and a control group in northern Norway.

C. Nieder, J. Norum, 2012, International Journal of Circumpolar Health.

Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer

C. Nieder, E. Haukland, Bărd Mannsăker, 2017, Cureus.

Hypofractionated Stereotactic Radiotherapy for Malignant Glioma: A Phase I/II Study

U. Nestle, C. Nieder, K. Schnabel, 1999 .

Hypofractionated stereotactic radiotherapy for malignant glioma—a pase I/II study

U. Nestle, C. Nieder, K. Schnabel, 1998 .

Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?

K. Ang, V. Grégoire, C. Nieder, 2001, International journal of radiation oncology, biology, physics.

External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors

M. Flentje, C. Nieder, R. Klement, 2019, Clinical and translational radiation oncology.

A population-based study of the pattern of terminal care and hospital death in patients with non-small cell lung cancer.

R. Bremnes, C. Nieder, J. Norum, 2012, Anticancer research.

Validation of the graded prognostic assessment index for surgically treated patients with brain metastases.

H. Geinitz, M. Molls, C. Nieder, 2008, Anticancer Research.

Estimating need for palliative external beam radiotherapy in adult cancer patients.

C. Nieder, A. Pawinski, A. Dalhaug, 2010, International journal of radiation oncology, biology, physics.

Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors.

C. Nieder, K. Marienhagen, L. Hoem, 2016, Oncology letters.

Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.

H. Geinitz, R. Thamm, M. Molls, 2012, International journal of radiation oncology, biology, physics.

A new prognostic score derived from phase I study participants with advanced solid tumours is also valid in patients with brain metastasis.

C. Nieder, A. Dalhaug, 2010, Anticancer research.

Undesirable financial effects of head and neck cancer radiotherapy during the initial treatment period.

C. Nieder, H. Egestad, 2015, International journal of circumpolar health.

Correction to expert consensus on re-irradiation for recurrent glioma

K. Camphausen, C. Tsien, J. Fiveash, 2018, Radiation Oncology.

Expert consensus on re-irradiation for recurrent glioma

K. Camphausen, C. Tsien, J. Fiveash, 2017, Radiation oncology.

Treatment of unresectable glioblastoma multiforme.

A. Grosu, M. Molls, C. Nieder, 2005, Anticancer research.

Contribution of Serum Biomarkers to Prognostic Assessment in Patients With Oligometastatic Prostate Cancer

C. Nieder, A. Pawinski, A. Dalhaug, 2019, In Vivo.

Second Re-irradiation: Clinical Examples of Worthwhile Treatment

C. Nieder, Rosalba Yobuta, Bărd Mannsăker, 2018, Cureus.

Scientific impact of studies published in temporarily available radiation oncology journals: a citation analysis

H. Geinitz, A. Grosu, N. Andratschke, 2015, SpringerPlus.

Independent Validation of a Unifying Prognostic Model for Intracranial and Extracranial Metastasis-directed Radiotherapy

C. Nieder, E. Haukland, B. Mannsăker, 2023, AntiCancer Research.

Ipilimumab in patients with melanoma and brain metastases.

C. Nieder, 2012, The Lancet. Oncology.

Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome

C. Nieder, A. Pawinski, A. Dalhaug, 2019, Cureus.

Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort

C. Nieder, E. Haukland, B. Mannsăker, 2022, AntiCancer Research.

Long-term survival results after treatment for oligometastatic brain disease.

A. Grosu, C. Nieder, A. Bilger, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure.

Michael Molls, Reinhard Thamm, Carsten Nieder, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose-Escalated High-Precision Radiotherapy: a Method to Overcome Variations in Biology and Radiosensitivity Limiting the Success of Conventional Approaches?

M. Mehta, C. Nieder, 2009 .

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?

A. Grosu, C. Nieder, I. Popp, 2023, Cancers.

Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors

C. Nieder, J. Norum, A. Pawinski, 2013, Clinical & Experimental Metastasis.

Prospective randomized clinical studies involving reirradiation

Johannes A. Langendijk, Matthias Guckenberger, Anca L. Grosu, 2016, Strahlentherapie und Onkologie.

The role of postoperative radiotherapy after resection of a single brain metastasis: Combined analysis of 497 patients

A. Grosu, N. Andratschke, M. Molls, 2007 .

Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case report

C. Nieder, J. Norum, A. Pawinski, 2008, The CASE Journal.

[Chemo- versus radiochemotherapy in stage III non-small-cell lung cancer with poor prognosis: the Conrad Study].

C. Nieder, 2014, Strahlentherapie und Onkologie (Print).

Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases

H. Geinitz, A. Grosu, N. Andratschke, 2012, Medical Oncology.

Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.

M. Schwaiger, H. Feldmann, A. Grosu, 2002, International journal of radiation oncology, biology, physics.

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?

A. Grosu, N. Andratschke, C. Nieder, 2023, Frontiers in Oncology.

Glioma treatment, radionecrosis, and growth factors. In regard to Levin et al., IJROBP 2002;53:58-66.

C. Nieder, 2003, International journal of radiation oncology, biology, physics.

Re-irradiation for recurrent head and neck cancer: in regard to Lee et Al. (Int j radiat oncol biol phys 2007;68:731-740).

C. Nieder, 2007, International journal of radiation oncology, biology, physics.

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?

C. Nieder, O. Spanne, A. Dalhaug, 2013, ISRN oncology.

Modification of radiation response : cytokines, growth factors, and other biological targets

K. Ang, L. Milas, C. Nieder, 2003 .

Repeat palliative radiotherapy for painful bone metastases.

C. Nieder, 2014, The Lancet. Oncology.

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)

A. Grosu, C. Nieder, O. Oehlke, 2017, Radiation oncology.

Influence of whole-brain radiotherapy on remission of brain metastases.

C. Nieder, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor Volume Reduction From 3 Gy-Fractions in Brain Metastases and Implications for Combined Treatment

A. Grosu, N. Andratschke, R. Thamm, 2005 .

[Brain metastases of bronchial and breast carcinoma. Differences in metastatic behavior and prognosis].

C. Nieder, T. Hagen, M. Niewald, 1995, Der Radiologe.

Brain metastases in patients under 50 years of age: retrospective analysis

H. Geinitz, A. Grosu, N. Andratschke, 2012, Clinical & Experimental Metastasis.

Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels

C. Nieder, J. Norum, A. Dalhaug, 2012, TheScientificWorldJournal.

41: Motexafin Gadolinium (MGd) Combined With Prompt Whole Brain Radiation Therapy Prolongs Time to Neurologic Progression in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases: Results of a Randomized Phase 3 Trial

M. Mehta, Jennifer A. Smith, Y. Ung, 2006 .

A Challenging Picture of Cancer-and Inflammation-Related Changes

C. Nieder, A. Dalhaug, Rolf Steen, 2009, Clinical medicine. Oncology.

Is Whole-Brain Radiotherapy Effective and Safe in Elderly Patients with Brain Metastases?

H. Geinitz, R. Thamm, M. Molls, 2008, Oncology.

NovoTTF-100A versus Chemotherapie

C. Nieder, 2013, Info Onkologie.

Carcinomatous Meningitis Appearing as Acoustic Neuromas

A. Grosu, C. Nieder, J. Gaa, 2007, Strahlentherapie und Onkologie.

Sunitinib, Sorafenib, Temsirolimus or Bevacizumab in Thetreatment of Metastatic Renal Cell Carcinoma: A Review of Health Economic Evaluations

C. Nieder, J. Norum, M. Kondo, 2010, Journal of chemotherapy.

Updated analysis of the phase III, double-blind, randomized, multinational study of radium-223 chloride in castration-resistant prostate cancer (CRPC) patients with bone metastases (ALSYMPCA).

D. Amadori, S. Fosså, A. Haese*, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How we treat octogenarians with brain metastases

A. Grosu, N. Andratschke, C. Nieder, 2023, Frontiers in oncology.

Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)

D. Amadori, S. Fosså, C. Parker, 2011 .

Prognostic Factors and Independent Validation of a Risk Stratification Model in Octogenarian Patients Irradiated for Brain Metastases

C. Nieder, A. Dalhaug, 2023, AntiCancer Research.

Days at home in the last three months of life: patterns-of-care analysis in patients with non-small cell lung cancer

C. Nieder, S. G. Aanes, E. Haukland, 2023, Contemporary oncology.

Modification of Radiation Response

K. Ang, L. Milas, C. Nieder, 2003 .

Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)

A. Grosu, N. Andratschke, C. Nieder, 2022, Frontiers in Oncology.

Prospective randomized clinical studies involving reirradiation: update of a systematic review

N. Andratschke, C. Nieder, J. Willmann, 2023, Strahlentherapie und Onkologie.

Gene Expression Profiling

W. Morgan, C. Rübe, W. Thorstad, 2021, Encyclopedia of Molecular Pharmacology.

Landmark Studies in Radiation Oncology: Has the Pattern of Publication Changed?

H. Geinitz, A. Grosu, N. Andratschke, 2013 .

Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research

C. Nieder, A. Pawinski, A. Dalhaug, 2015, Tumor Biology.

External Validation of the LabBM Score in Patients With Brain Metastases

C. Nieder, A. Pawinski, A. Dalhaug, 2019, Journal of clinical medicine research.

Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain Radiotherapy

C. Nieder, A. Pawinski, A. Dalhaug, 2020, Anticancer Research.

Stereotactic radiosurgery for brain metastasis from renal cell carcinoma

D. Kondziolka, J. Flickinger, L. Lunsford, 1999, Cancer.

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review

L. Gaspar, A. Grosu, C. Nieder, 2014, Radiation Oncology.

Normal Tissue Tolerance to Reirradiation

J. Langendijk, C. Nieder, 2010 .

Presentation and outcome in cancer patients with extensive spread to the brain

C. Nieder, A. Dalhaug, Adam Pawiniski, 2009, BMC Research Notes.

The LabPS score

C. Nieder, A. Dalhaug, E. Haukland, 2023, American journal of clinical oncology.

Independent Validation of a Risk Stratification Model Predicting Survival in Elderly Patients Irradiated for Bone Metastases

C. Nieder, E. Haukland, B. Mannsăker, 2023, AntiCancer Research.

Experimental concepts for toxicity prevention and tissue restoration after central nervous system irradiation

N. Andratschke, C. Nieder, S. Astner, 2007, Radiation oncology.

Palliative non-small cell lung cancer treatment and end-of-life care stratified by sex and childlessness: an important interplay in unmarried patients?

C. Nieder, E. Haukland, S. Aanes, 2022, Supportive Care in Cancer.